DuRoss Amy

Insider profile

Performance

Overall performance
3.1

Performance over holding periods
3.1
30 days 90 days 120 days
Average return 4% 8.2% 15.1%
Success rate 60% 68% 82%
Transactions
9 0% Buy
34 71% Buy
47 69% Buy
DuRoss Amy's trades of Biolife Solutions Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-12-17 2025-12-15 S Sale
66,528 -39.4%
166.03
US$2,870,390
66,528 -39.4% 166.03 US$2,870,390
2025-11-28 2025-11-26 S Sale
30,822 +44.8%
235.58
US$1,985,790
30,822 +44.8% 235.58 US$1,985,790
2025-11-28 2025-11-25 S Sale
72,001 +23.4%
30.30
US$503,504
72,001 +23.4% 30.30 US$503,504
2025-11-21 2025-11-21 S Sale
1,000 -3.9%
26.00
US$26,000
1,000 -3.9% 26.00 US$26,000
2025-11-21 2025-11-20 S Sale
4,523 -15.0%
24.51
US$110,859
4,523 -15.0% 24.51 US$110,859
2025-11-21 2025-11-19 S Sale
477 -1.6%
24.50
US$11,686
477 -1.6% 24.50 US$11,686
2025-11-12 2025-11-12 PrS Proposed sale
12,000
26.38
US$316,560
12,000 26.38 US$316,560
2025-03-20 2025-03-14 PlS Planned sale
5,632 -19.1%
24.96
US$140,575
5,632 -19.1% 24.96 US$140,575
2025-03-14 2025-03-14 PrS Proposed sale
5,632
25.06
US$141,138
5,632 25.06 US$141,138
2024-03-13 2024-03-13 S Sale
5,065 -14.7%
17.00
US$86,105
5,065 -14.7% 17.00 US$86,105
2024-03-13 2024-03-12 S Sale
6,135 -15.1%
16.86
US$103,436
6,135 -15.1% 16.86 US$103,436
2024-03-12 2024-03-12 PrS Proposed sale
11,200
16.98
US$190,176
11,200 16.98 US$190,176
2022-11-17 2022-11-15 S Sale
2,600 -12.5%
24.35
US$63,310
2,600 -12.5% 24.35 US$63,310